Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
出版年份 2022 全文链接
标题
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
作者
关键词
-
出版物
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
Volume 47, Issue 6, Pages 855-868
出版商
Springer Science and Business Media LLC
发表日期
2022-09-30
DOI
10.1007/s13318-022-00793-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
- (2021) Daryl Hodge et al. CLINICAL PHARMACOKINETICS
- Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial
- (2021) Jean-Michel Molina et al. Lancet HIV
- Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe
- (2021) Alejandro J. Paredes et al. ADVANCED DRUG DELIVERY REVIEWS
- Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
- (2021) Kelly Bleasby et al. Viruses-Basel
- Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial
- (2021) Randolph P. Matthews et al. NATURE MEDICINE
- Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial
- (2020) Dirk Schürmann et al. Lancet HIV
- Long-acting approaches for delivery of antiretroviral drugs for prevention and treatment of HIV: a review of recent research
- (2020) Denise A. Cobb et al. Expert Opinion on Drug Delivery
- Microneedle Array: Applications, Recent Advances, and Clinical Pertinence in Transdermal Drug Delivery
- (2020) Jitu Halder et al. Journal of Pharmaceutical Innovation
- Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
- (2020) Edgar T Overton et al. LANCET
- Microneedle array systems for long-acting drug delivery
- (2020) Lalit K. Vora et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK
- (2019) Rajith K.R. Rajoli et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Extended Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention
- (2018) Stephanie E. Barrett et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
- (2018) Mohamad Shebley et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591
- (2018) Martin Markowitz et al. Current Opinion in HIV and AIDS
- The promise and pitfalls of long-acting injectable agents for HIV prevention
- (2016) Raphael J. Landovitz et al. Current Opinion in HIV and AIDS
- Oral Administration of the Nucleoside EFdA (4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine) Provides Rapid Suppression of HIV Viremia in Humanized Mice and Favorable Pharmacokinetic Properties in Mice and the Rhesus Macaque
- (2015) Cheryl A. Stoddart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers
- (2014) Wei Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- 4′-Ethynyl-2-fluoro-2′-deoxyadenosine (EFdA) Inhibits HIV-1 Reverse Transcriptase with Multiple Mechanisms
- (2014) Eleftherios Michailidis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HIV infection: epidemiology, pathogenesis, treatment, and prevention
- (2014) Gary Maartens et al. LANCET
- Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients
- (2014) M. Gajewska et al. TOXICOLOGY LETTERS
- An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry
- (2012) Sieto Bosgra et al. CRITICAL REVIEWS IN TOXICOLOGY
- Setting Up a Standardized Peripheral Blood Mononuclear Cells Processing Laboratory to Support Multi-center HIV/AIDS Vaccine and Intervention Trials
- (2011) Harr Freeya Njai et al. Labmedicine
- Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape Analysis
- (2008) Sheila Annie Peters CLINICAL PHARMACOKINETICS
- Prediction of drug distribution within blood
- (2008) Paulo Paixão et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More